The Inflation Reduction Act aims to lower drug costs — but here’s how big pharma could get around it

NBC News

21 September 2022 - The tactics may ultimately threaten the law’s ability to lower drug costs for many in the US.

The law takes aim at insulin costs, caps out of pocket spending for Medicare beneficiaries, and allows the federal government to negotiate prices on the costliest prescription drugs. It also will require drug makers to pay a rebate to Medicare if they raise prices too sharply.

Read NBC News article

Michael Wonder

Posted by:

Michael Wonder